Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives.
Gaining insight into the mechanism of amyloid fibril formation, the hallmark of multiple degenerative syndromes of unrelated origin, and exploring novel directions of inhibition are crucial for preventing disease development. Specific interactions between aromatic moieties were suggested to have a key role in the recognition and self-assembly processes leading to the formation of amyloid fibrils by several amyloidogenic polypeptides, including the beta-amyloid polypeptide associated with Alzheimer's disease. Our finding of the high-affinity molecular recognition and intense amyloidogenic potential of tryptophan-containing peptide fragments led to the hypothesis that screening for indole derivatives might lead to the identification of potential inhibitors of amyloid formation. Such inhibitors could mediate specific recognition processes without allowing further growth of the well-ordered amyloid chain. Using fluorescence spectroscopy, atomic force microscopy, and electron microscopy to screen 29 indole derivatives, we identified three potent inhibitors: indole-3-carbinol (I3C), 3-hydroxyindole (3HI), and 4-hydroxyindole (4HI). The latter, a simple low-molecular weight aromatic compound, was the most effective, completely abrogating not only the formation of aggregated structures by Abeta but also the cytotoxic activity of aggregated Abeta toward cultured cells. The results of this study provide further experimental support for the paradigm of amyloid inhibition by heteroaromatic interaction and point to indole derivatives as a simple molecular platform for the development of novel fibrillization inhibitors.
Cohen
Tomer
T
Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel.
Frydman-Marom
Anat
A
Rechter
Meirav
M
Gazit
Ehud
E
D000682:Amyloid / Q000037:antagonists & inhibitors* / Q000378:metabolism* / Q000633:toxicity; D000818:Animals; D000975:Antioxidants / Q000378:metabolism / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D007211:Indoles / Q000378:metabolism / Q000494:pharmacology*; D007700:Kinetics; D046529:Microscopy, Electron, Transmission; D016716:PC12 Cells; D010446:Peptide Fragments / Q000378:metabolism; D051381:Rats; D013050:Spectrometry, Fluorescence; D013329:Structure-Activity Relationship; D013997:Time Factors
D000682:Amyloid; D000975:Antioxidants; D007211:Indoles; D010446:Peptide Fragments; C510548:4-hydroxyindole; C030374:indole; C510549:3-hydroxyindole; C016517:indole-3-carbinol